Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.62+0.02 (+0.19%)
Close on Nov 18, 2026Market cap $893.06MP/E 13.8Yield –
Bioventus gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Bioventus's gross profit for the twelve months ending Jun 27, 2026 was $399.45M, up 4.7% year over year. For fiscal 2025 it was $388.16M, down 0.0% from the year before. The highest annual figure on record is $388.23M in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $388.16M | -0.0% |
| FY2024 | Dec 31, 2024 | $388.23M | +18.3% |
| FY2023 | Dec 31, 2023 | $328.19M | -0.9% |
| FY2022 | Dec 31, 2022 | $331.08M | +9.4% |
| FY2021 | Dec 31, 2021 | $302.71M | +29.6% |
| FY2020 | Dec 31, 2020 | $233.52M | -6.3% |
| FY2019 | Dec 31, 2019 | $249.21M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 27, 2026 | $105.67M | +3.5% |
| Q1 FY2026 | Mar 28, 2026 | $90.77M | +9.3% |
| Q4 FY2025 | Dec 31, 2025 | $108.78M | +6.0% |
| Q3 FY2025 | Sep 27, 2025 | $94.23M | +0.7% |
| Q2 FY2025 | Jun 28, 2025 | $102.09M | -1.5% |
| Q1 FY2025 | Mar 29, 2025 | $83.06M | -6.0% |
| Q4 FY2024 | Dec 31, 2024 | $102.66M | +19.0% |
| Q3 FY2024 | Sep 28, 2024 | $93.55M | +18.6% |
| Q2 FY2024 | Jun 29, 2024 | $103.64M | +16.3% |
| Q1 FY2024 | Mar 30, 2024 | $88.38M | +19.6% |
| Q4 FY2023 | Dec 31, 2023 | $86.30M | +16.3% |
| Q3 FY2023 | Sep 30, 2023 | $78.85M | -6.7% |
| Q2 FY2023 | Jul 1, 2023 | $89.12M | -7.8% |
| Q1 FY2023 | Apr 1, 2023 | $73.92M | -2.4% |
| Q4 FY2022 | Dec 31, 2022 | $74.19M | -15.5% |
| Q3 FY2022 | Oct 1, 2022 | $84.54M | +6.9% |
| Q2 FY2022 | Jul 2, 2022 | $96.65M | +26.7% |
| Q1 FY2022 | Apr 2, 2022 | $75.70M | +27.1% |
| Q4 FY2021 | Dec 31, 2021 | $87.77M | +19.5% |
| Q3 FY2021 | Oct 2, 2021 | $79.07M | +26.6% |
| Q2 FY2021 | Jul 3, 2021 | $76.31M | +89.1% |
| Q1 FY2021 | Apr 3, 2021 | $59.56M | +4.1% |
| Q4 FY2020 | Dec 31, 2020 | $73.47M | – |
| Q3 FY2020 | Sep 26, 2020 | $62.46M | – |
| Q2 FY2020 | Jun 27, 2020 | $40.35M | – |
| Q1 FY2020 | Mar 28, 2020 | $57.24M | – |
See a number that looks wrong?